| Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint T Bruno, F De Nicola, S Iezzi, D Lecis, C D'Angelo, M Di Padova, N Corbi, ... Cancer cell 10 (6), 473-486, 2006 | 147 | 2006 |
| Chemotherapeutic compounds targeting the DNA double-strand break repair pathways: the good, the bad, and the promising C Jekimovs, E Bolderson, A Suraweera, M Adams, KJ O’Byrne, ... Frontiers in Oncology 4, 86, 2014 | 142 | 2014 |
| Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals CR Jekimovs, X Chen, J Arnold, M Gatei, DJ Richard, AB Spurdle, ... British journal of cancer 92 (4), 784-790, 2005 | 57 | 2005 |
| Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer A Suraweera, A Duff, MN Adams, C Jekimovs, PHG Duijf, C Liu, ... British Journal of Cancer 123 (4), 591-603, 2020 | 20 | 2020 |
| COMMD1, from the repair of DNA double strand breaks, to a novel anti-cancer therapeutic target A Suraweera, PHG Duijf, C Jekimovs, K Schrobback, C Liu, MN Adams, ... Cancers 13 (4), 830, 2021 | 5 | 2021 |
| Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer A Suraweera, A Duff, MN Adams, C Jekimovs, PHG Duijf, C Liu, ... British Journal of Cancer 124 (9), 1612, 2021 | | 2021 |
| 216P COMMD1 in non-small cell lung cancer: A novel DNA repair protein as a therapeutic target and diagnostic biomarker A Suraweera, P Duijf, M Tang, C Jekimovs, K Schrobback, C Liu, ... Journal of Thoracic Oncology 16 (4), S813, 2021 | | 2021 |
| P1. 03-05 COMMD4 in Lung Cancer: Towards a New Therapeutic Target and Diagnostic Biomarker A Suraweera, M Adams, C Jekimovs, D Richard, K O'Byrne Journal of Thoracic Oncology 14 (10), S419, 2019 | | 2019 |
Derek RichardQueensland University of Technology在 qut.edu.au 的电子邮件经过验证
